Form 4 for RIGL RIGEL PHARMACEUTICALS INC
Accepted 2025-02-06 00:00:00 ET · period of report 2025-02-04 · accession 0000905148-25-000411 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-06 | 2025-02-04+ | RIGL | RODRIGUEZ RAUL R | CEO, Pres, Dir | S - Sale | $21.40 | -9,352 | 239.5K | -4% | -$200.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-04 | S | D | 4,952 | $20.92 | 243,854 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-05 | S | D | 4,400 | $21.93 | 239,454 | D | — | — |